Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Adhoc Press Release
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Annual General Meeting of Kuros Biosciences approves all resolutions
Adhoc Press Release
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand